User login

The Florida Society of Ophthalmology

The EyeMDs


News from the FSO

From the American Academy of Ophthalmology

As expected, a 27 percent reduction in payments is included in the proposed 2013 Medicare physician fee schedule released today by the Centers for Medicare and Medicaid Services (CMS). The cut is due to continuation of the flawed sustainable growth rate (SGR) formula. Ongoing, SGR-driven uncertainty will continue into the upcoming elections. If the SGR cut is halted as in past years, ophthalmology payments in general would increase by 1 percent in 2013, according to CMS.

Tuesday, July 10, 2012 - 11:00

From the American Academy of Ophthalmology

This was the first population-based study on periocular infantile hemangiomas in the United States. Over the 40-year period analyzed, the incidence was 1 in 1,586 live births and was most prevalent in white females with unilateral upper eyelid involvement. One in 5 had a history of maternal infertility, and 1 in 8 were born prematurely. Nine (21%) had an additional hemangioma outside the periocular region. Archives of Ophthalmology, July 2012

Friday, July 27, 2012 - 10:45

From the American Academy of Ophthalmology

Monday, July 30, 2012 - 10:45

Florida Society of Ophthalmology’s Proposals Receive Approval Regarding Inclusion and Scope of Practice Expansion
 

Tuesday, July 31, 2012 - 10:45

From the American Academy of Ophthalmology

Friday, August 3, 2012 - 10:45

From the American Academy of Ophthalmology

Thursday, August 9, 2012 - 10:30

From the American Academy of Ophthalmology

Tuesday, August 14, 2012 - 10:30

From the American Academy of Ophthalmology

Friday, August 17, 2012 - 10:30

From the American Academy of Ophthalmology

The U.S. Food and Drug Administration has approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. The drug’s safety and effectiveness to treat DME were established in two clinical studies that showed a 34 to 45 percent improvement in patients treated monthly with 0.3 mg of Lucentis over a two-year period. Ophthalmologists should check with their Medicare carriers to determine coverage for Lucentis to treat DME.

Friday, August 17, 2012 - 10:30

From the American Academy of Ophthalmology

 

Tuesday, August 28, 2012 - 10:15

Pages

FSO

About

 
 
 
 
 
 

For Eye Care Foundation

 
 
 
 
 
 
 
 

Join

 
 
 
 

Contribute

Pay Dues

Upcoming Events

Thursday, February 13, 2025 to Sunday, February 16, 2025
Hilton Orlando Bonnet Creek
Orlando, FL
Thursday, February 20, 2025
Venue TBD
Palm Beach Gardens, FL
Wednesday, February 26, 2025
3:00-5:00 PM ET
Zoom
Wednesday, February 26, 2025 to Sunday, March 2, 2025
Washington, DC
Wednesday, April 2, 2025 to Saturday, April 5, 2025
Westin Washington DC Downtown Hotel
Washington, DC
Friday, April 25, 2025 to Monday, April 28, 2025
Los Angeles, CA
Friday, June 6, 2025 to Sunday, June 8, 2025
Waldorf Astoria Orlando
Orlando, FL
Friday, July 25, 2025 to Sunday, July 27, 2025
Hyatt Regency Orlando
Orlando, FL
Wednesday, July 30, 2025 to Saturday, August 2, 2025
Southern California at Long Beach
Thursday, August 7, 2025 to Sunday, August 10, 2025
The Ritz-Carlton Amelia Island
Amelia Island, FL
Friday, October 17, 2025 to Monday, October 20, 2025
Orange County Convention Center
Orlando, FL